You have 9 free searches left this month | for more free features.

Anti-MUC1 Vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Miami (drug, biological, other)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Miami, Florida
    University of Miami
Jun 10, 2021

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

Advanced Breast Cancer, Breast Tumor Malignant Female Trial in Guangzhou (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Completed
  • Advanced Breast Cancer
  • Breast Neoplasm Malignant Female
  • AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Apr 11, 2023

Lung Carcinoma Trial in Rochester, Pittsburgh (Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine)

Active, not recruiting
  • Lung Carcinoma
  • Laboratory Biomarker Analysis
  • MUC1 Peptide-Poly-ICLC Vaccine
  • Rochester, Minnesota
  • +1 more
Feb 24, 2022

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Falimarev
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 4, 2022

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)

Recruiting
  • NSCLC
  • EGFR Gene Mutation
  • neo-antigen vaccine
  • Nanjing, China
    The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

Active, not recruiting
  • Melanoma (Skin)
  • NY-ESO-1 157-165 (165V)
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

Withdrawn
  • Recurrent Human Papillomavirus Type 16 Associated Cancer
  • HPV 16 TA-CIN
  • Birmingham, Alabama
  • +1 more
Nov 29, 2022

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Blood sample collection
  • +4 more
  • Besançon, France
  • +4 more
Nov 17, 2022

Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide

Not yet recruiting
  • Ovarian Cancer Stage IV
  • +2 more
  • Washington, District of Columbia
  • +2 more
Jul 28, 2022

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

Not yet recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Anti-Rabies Vaccine
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev

Active, not recruiting
  • Malignant Melanoma, Metastatic
  • +2 more
  • Herlev, Denmark
  • +1 more
Jan 10, 2022

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022